1. Home
  2. TELA

as of 12-15-2025 2:56pm EST

$1.13
$0.02
-1.74%
Stocks Health Care Medical/Dental Instruments Nasdaq

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Chart Type:
Time Range:
Founded: 2012 Country:
United States
United States
Employees: N/A City: MALVERN
Market Cap: 51.2M IPO Year: 2019
Target Price: $3.31 AVG Volume (30 days): 356.9K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.89 EPS Growth: N/A
52 Week Low/High: $0.86 - $3.10 Next Earning Date: 11-13-2025
Revenue: $77,055,000 Revenue Growth: 12.24%
Revenue Growth (this year): 18.39% Revenue Growth (next year): 15.34%

AI-Powered TELA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 75.33%
75.33%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of TELA Bio Inc. (TELA)

TELA Nov 17, 2025

Avg Cost/Share

$1.11

Shares

3,604,000

Total Value

$4,000,440.00

Owned After

7,714,709

SEC Form 4

Latest TELA Bio Inc. News

TELA Breaking Stock News: Dive into TELA Ticker-Specific Updates for Smart Investing

All TELA News

Share on Social Networks: